Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Karen Weaver Joins Epstein Becker & Green, P.C.
Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG).
- Karen Weaver Joins Epstein Becker & Green, P.C.
Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG).
- Karen Weaver Joins Epstein Becker & Green, P.C.
Karen Weaver, and her two associates, formerly of the Weaver Law Group, LLC have joined the Chicago office of Epstein Becker and Green, P.C. (EBG).
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- Zuellig Appoints George Pontiakos President and CEO of North American Operations
Company announces the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America, to oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- NHPRS Annual Research Conference and Tradeshow Focuses on the Latest Research Advances
The conference, to be held March 3-5, 2006, Toronto, Ontario, Canada, at the Downtown Marriott Eaton's Centre, features keynote addresses from the world's leading natural health product (NHP) experts and the latest research advances peer-selected from a global call for papers.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- Unigen Pharmaceuticals Hires Director of Clinical Research
Unigen Pharmaceuticals, Inc. has announced the hiring of the company’s first Director of Clinical Research, Terry E. O’Reilly, M.D.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
Company received $936,375 in financing from the Cystic Fibrosis Foundation to develop and commercialize a formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis patients.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- CK Life Sciences Spends $1.3b (US$166 million) to Expand into US Nutraceutical Market
CK Life Sciences Int’l., Inc. will acquire an 80% direct interest in Vitaquest at a purchase price of HK$1,291.5 million (US$166 million), subject to adjustment at closing.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- HerbDay 2006 Scheduled for October 14th - Events Planned to 'Celebrate Herbs and Herbalism'
Five national non-profit organizations working together as the HerbDay Coalition announced today that the first annual HerbDay will be held on Saturday, October 14, 2006 - HerbDay is a coordinated series of public educational events celebrating the importance of herbs and herbalism, with activities occurring at retail stores, botanical gardens and parks throughout North America.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies
The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population.
- Upcoming Event: State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention
The Office of Dietary Supplements and the Office of Medical Applications of Research of the National Institutes of Health are convening a Consensus Conference on the State of the Science regarding MultiVitamins and Minerals and Chronic Disease, May 15-17, 2006, at the Natcher Conference Center, National Institutes of Health, Bethesda, MD.
- Upcoming Event: State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention
The Office of Dietary Supplements and the Office of Medical Applications of Research of the National Institutes of Health are convening a Consensus Conference on the State of the Science regarding MultiVitamins and Minerals and Chronic Disease, May 15-17, 2006, at the Natcher Conference Center, National Institutes of Health, Bethesda, MD.
- Upcoming Event: State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention
The Office of Dietary Supplements and the Office of Medical Applications of Research of the National Institutes of Health are convening a Consensus Conference on the State of the Science regarding MultiVitamins and Minerals and Chronic Disease, May 15-17, 2006, at the Natcher Conference Center, National Institutes of Health, Bethesda, MD.
- Upcoming Event: State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention
The Office of Dietary Supplements and the Office of Medical Applications of Research of the National Institutes of Health are convening a Consensus Conference on the State of the Science regarding MultiVitamins and Minerals and Chronic Disease, May 15-17, 2006, at the Natcher Conference Center, National Institutes of Health, Bethesda, MD.
- Upcoming Event: State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention
The Office of Dietary Supplements and the Office of Medical Applications of Research of the National Institutes of Health are convening a Consensus Conference on the State of the Science regarding MultiVitamins and Minerals and Chronic Disease, May 15-17, 2006, at the Natcher Conference Center, National Institutes of Health, Bethesda, MD.
- 2006 Functional Foods Japan Product Report Now Available
This 140 page report features over 300 products in 17 unregulated functional food product categories and 8 FOSHU categories, and is invaluable for companies planning to develop new products or looking for new product development inspirations.
- 2006 Functional Foods Japan Product Report Now Available
This 140 page report features over 300 products in 17 unregulated functional food product categories and 8 FOSHU categories, and is invaluable for companies planning to develop new products or looking for new product development inspirations.
- 2006 Functional Foods Japan Product Report Now Available
This 140 page report features over 300 products in 17 unregulated functional food product categories and 8 FOSHU categories, and is invaluable for companies planning to develop new products or looking for new product development inspirations.
- 2006 Functional Foods Japan Product Report Now Available
This 140 page report features over 300 products in 17 unregulated functional food product categories and 8 FOSHU categories, and is invaluable for companies planning to develop new products or looking for new product development inspirations.
- 2006 Functional Foods Japan Product Report Now Available
This 140 page report features over 300 products in 17 unregulated functional food product categories and 8 FOSHU categories, and is invaluable for companies planning to develop new products or looking for new product development inspirations.
- Wayne Bos Joins Natrol as CEO Designate
Board of Directors has elected Wayne Bos as the Company's Chief Executive Officer and President designate, to assume his new duties next month. Plans include "to develop Natrol as a solid, profitable growth company, to focus on growing internationally and to ensure that we are opportunistic with regard to acquisitions."
- Wayne Bos Joins Natrol as CEO Designate
Board of Directors has elected Wayne Bos as the Company's Chief Executive Officer and President designate, to assume his new duties next month. Plans include "to develop Natrol as a solid, profitable growth company, to focus on growing internationally and to ensure that we are opportunistic with regard to acquisitions."
- Wayne Bos Joins Natrol as CEO Designate
Board of Directors has elected Wayne Bos as the Company's Chief Executive Officer and President designate, to assume his new duties next month. Plans include "to develop Natrol as a solid, profitable growth company, to focus on growing internationally and to ensure that we are opportunistic with regard to acquisitions."
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain
Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Santa Fe Springs, CA, February 6, 2006 – Jarrow Industries, Inc, a 45,000-square-foot contract manufacturing facility, has announced it has achieved Good Manufacturing Practices (GMP) Registration through NSF International’s Dietary Supplement Certification program. Jarrow Industries successfully met all requirements included in NSF’s GMP Registration Program. Jarrow Industries provides a one-stop, full spectrum of services from formulation to encapsulation, tablet manufacturing, tablet coating and bottle and blister packaging of vitamins and nutritional supplement products for Jarrow Formulas and other private label customers.
GMPs are regulatory requirements that provide guidelines for necessary processes, procedures and documentation to assure the product produced has the identity, strength, composition, quality and purity it is represented to possess. NSF conducted a plant audit to verify compliance with GMPs and will conduct periodic audits at Jarrow Industries to ensure continued conformance. GMPs for the current NSF Dietary Supplements Program are included in NSF American National Standard 173 – Dietary Supplements, the only American National Standard for Dietary Supplements.
Jarrow Industries GMP registration reflects their continued commitment to ensuring quality and satisfaction and gives companies confidence that their organization operates in conformance to registration certificate and is listed on the NSF website.
According to Siva P. Hari, Ph.D., President and CEO, of Jarrow Industries, GMP registration is a process any reputable contract manufacturer should accomplish. “This facility was designed to be one of the highest quality supplement facilities in the United States. From day one it has always been a top priority to provide effective and affordable products and services from formulations to finished goods that are based on cGMPs.”
NSF International, an independent, not-for-profit organization, helps protect you by certifying products and writing standards for food, water, air and consumer goods (www.nsf.org). Founded in 1944, NSF is committed to protecting public health and safety worldwide. NSF is a World Health Organization Collaborating Center for Food and Water Safety and Indoor Environment. Additional services include safety audits for the food and water industries, management systems registrations delivered through NSF International Strategic Registrations, Ltd., organic certification provided by Quality Assurance International and education through the NSF Center for Public Health Education.
Jarrow Industries Inc., a 45,000-square-foot contract manufacturing facility located at 12246 Hawkins Street in Santa Fe Springs, CA, incorporates the very latest dietary supplement technology. Jarrow Industries, Inc. is a Class 10,000 capable (a rating that will permit it to handle OTCs and pharmaceuticals) and ultra low humidity control facility that produces Jarrow Formulas and private label products. Jarrow Industries, Inc. mission is reflected in its motto: “Reliable Quality and Superior Service.” The company’s philosophy is to encourage customers to visit and gain a complete sense of comfort and confidence with regard to its capabilities, cleanliness, quality and good manufacturing practices before placing an order. For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Industries’ Web site at www.jiimfg.com.
### |